food

Crypto Payments Come to Adelaide Oval via Crypto.com

Source Node:
Time Stamp: April 4, 2024 6:29 AM - Modified On: April 4, 2024 - Published By:
Source Cluster:
Republished By Plato

First-Ever Crypto Payment Integration for Major Stadium in Australia VIDEOS AND IMAGES AVAILABLE IN LINK BELOW Adelaide, April 4, 2024 - Crypto.com, trusted by more than 80 million customers worldwide and the industry leader in regulatory compliance, security and privacy, announced today that sports fans and concert-goers can now pay via Crypto.com Pay, Crypto.com’s payment solution, at Adelaide Oval, the home of the Adelaide Crows. Supported by Adelaide Oval, Adelaide Crows and financial systems software firm DataMesh, which is providing the payment technology and terminals, this integration will mark a

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

Source Node:
Time Stamp: February 7, 2024 10:50 AM - Modified On: February 7, 2024 - Published By:
Source Cluster:
Republished By Plato

Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio industry welcomed the parliament’s passage of a bill that adds regenerative medicine organizations to the list of those considered for human cell management business licenses. The National Assembly passed the “Amendment to the Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals” in a plenary session paving the way for certain next generation NK Cell Therapy companies to recognized as a licensed

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

SMI Vantage Signs Bitcoin Mining Lease Agreement

Source Node:
Time Stamp: December 6, 2023 6:18 AM - Modified On: December 6, 2023 - Published By:
Source Cluster:
Republished By Plato

Further to the Offer to Rent agreement previously announced in Sept 2023, the Company has now moved forward and signed a Lease Agreement SINGAPORE, Dec 6, 2023 - (ACN Newswire) - SMI Vantage Limited ("SMI" or the "Company"), a company listed on the mainboard of the SGX, is pleased to announce the signing of a Lease Agreement ("the Agreement") by its wholly-owned subsidiary SMI CS Pte Ltd. This is further to the previously announced Offer to Rent Agreement. The Agreement allows SMI Vantage to start Bitcoin-mining in a new location

GMEX ZERO13 wins COP28 TechSprint and continues network expansion

Source Node:
Time Stamp: December 6, 2023 5:56 AM - Modified On: December 6, 2023 - Published By:
Source Cluster:
Republished By Plato

Technology solution selected as winner for blockchain technology British innovation in digital sustainable finance showcased and recognised at COP28 Universal Carbon Registry, Decarb.earth, Koat Intelligence Solutions and Plato Data Intelligence added LONDON, UAE, 6 December 2023 – ZERO13, the GMEX Group initiative providing a digital climate fintech platform-as-a-service, is delighted to announce the addition of four new participants to its Asset Settlement Network and its selection as the winner of the prestigious COP28 TechSprint for blockchain technology. The COP28 TechSprint, launched by the Central Bank of the United Arab Emirates

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:55 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

NEW APPEAL TO PROVIDE SUPPORT TO THOUSANDS OF ISRAELI CITIZENS FOLLOWING HAMAS ASSAULT

Source Node:
Time Stamp: October 19, 2023 12:35 PM - Modified On: October 19, 2023 - Published By:
Source Cluster:
Republished By Plato

  Tel Aviv, New York & London; October 19, 2023: In the wake of the recent catastrophic and unprecedented attack that was launched at Israel by Hamas on and beyond October 7, Ahavat Yisroel Humanity Inc. has launched an urgent fundraising appeal in order to provide much-needed support and supplies to the thousands of Israeli citizens affected. The Israel Now, Israel Forever appeal is seeking donations to provide the many affected citizens with food, shelter, and urgent suppliers. The donations will be shared among four established and experienced relief organisations

Erez Capital Announces Additional Venture Partners

Source Node:
Time Stamp: August 4, 2023 6:52 AM - Modified On: August 4, 2023 - Published By:
Source Cluster:
Republished By Plato

Erez Capital, a emerging venture capital fund investing in disruptive technologies, is thrilled to announce the addition of new Venture Partners. Boston, Massachusetts, United States - August 3rd, 2023 — Erez Capital, a emerging venture capital fund investing in disruptive technologies, is thrilled to announce its addition of 40 Venture Partners to join the fund. These new partners will play an important role in the quickly developing artificial intelligence ecosystem - specifically in the proptech, medtech and fintech sectors. “This fund and its investments will represent the consensus of experts,

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

Source Node:
Time Stamp: July 27, 2023 8:30 AM - Modified On: July 27, 2023 - Published By:
Source Cluster:
Republished By Plato

ORLANDO, FL / July 27, 2023 / Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of its consumer sports recovery tape brand, Active Intelligence AI Tape (“AI Tape”), with products now available for purchase on Amazon and Activeintell.com. AI Tape is designed to combine many of the traditional benefits of kinesiology tape with the addition of soothing and therapeutic ingredients held in suspension with a proprietary adhesive mix. “We are very excited for the launch of our AI Tape brand, our first products targeting the consumer

Renowned Physician-Pharmacist Dr. Anita Gupta joins Erez Capital, Bringing Healthcare Innovation Expertise on Board.

Source Node:
Time Stamp: July 26, 2023 2:17 PM - Modified On: July 26, 2023 - Published By:
Source Cluster:
Republished By Plato

Boston, MA, July 26th, 2023-- Erez Capital is proud to announce the addition of Dr. Anita Gupta to its esteemed team of Venture Partners. Dr. Gupta, a global leader in healthcare innovation, is renowned for her ground-breaking contributions to the medical field and her exceptional expertise in anesthesiology and pain management. With an illustrious career and a portfolio of remarkable accomplishments, Dr. Anita Gupta has made a significant impact on healthcare innovation and patient advocacy. As a World Economic Forum Member Expert, she has been recognized as one of the

GMEX Group launches ZERO13 digital carbon credits aggregation ecosystem

Source Node:
Time Stamp: May 4, 2023 6:02 AM - Modified On: May 4, 2023 - Published By:
Source Cluster:
Republished By Plato

Partners with Verdana Eco-Consortium, Alléo Energy and Pay DIRT London., May. 4, 2023 -- GMEX Group Limited (“GMEX”), a leader in digital business and technology solutions for capital, commodities and sustainability markets, announces the launch of ZERO13, a climate fintech. ZERO13 provides an automated AI and multi-blockchain driven aggregation ecosystem delivering trusted supply, digital issuance, trading, clearing and settlement for a broad range of carbon credits and related ESG real-world assets. ZERO13 digitally interconnects multiple stakeholders, including registries, banks, custodians, asset managers, corporates, buyers and sellers, markets, exchanges, climate tech

NFT Street Fair Press Release

Source Node:
Time Stamp: May 18, 2022 7:52 AM - Modified On: May 18, 2022 - Published By:
Source Cluster:
Republished By Plato

Continuum Market, CaNectar and Brad Turner, present #NFTStreetFair, Saturday May 28th, to share our NFT economic explosions via vendor booths, two stages, Digital innovation immersive experiences, IRL + Webinar livestream, and more than a metaverse. Meet the best in blockchain NFT economy at City of Arts Costa Mesa, CA #NFTStreetFair @NFTStreetFair alongside investors and subject matter experts happy to share their knowledge. Join us at 3197 Red Hill, Costa Mesa, CA Saturday 5/28, 10am for the full day event. Friday night VIP cocktail party with gift bag, food and open